查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1943652

皮膚庫市場－全球產業規模、佔有率、趨勢、機會和預測（2021-2031）

Skin Bank Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, By Skin Graft, By Application, By Ownership, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球皮膚庫市場預計將從 2025 年的 24.3 億美元成長到 2031 年的 36.9 億美元，複合年成長率為 7.21%。

皮膚庫是專門從事人體皮膚同種異體移植片的採集、處理、保存和分發的醫療機構，這些移植片是治療嚴重燒燙傷和大量組織缺損所必需的生物敷料。皮膚庫的發展主要受燒燙傷病例增加和移植片保存技術進步的推動，這些進步延長了組織的存活時間。美國燒燙傷協會的數據凸顯了這一迫切需求，報告顯示，2024年全美114家中心共收治了32993例急性燒燙傷患者，這表明治療複雜創傷病例對活性供體組織的持續需求。

市場概覽
預測期 2027-2031
市場規模：2025年 24.3億美元
市場規模：2031年 36.9億美元
複合年成長率：2026-2031年 7.21%
成長最快的細分市場 難癒合性潰瘍
最大的市場 北美洲

儘管有這些市場促進因素，但由於皮膚捐贈長期短缺，該市場仍面臨許多障礙。這個問題主要源自於公眾意識不足以及文化和宗教因素對遺體捐贈的顧慮。這種短缺造成了供需之間的巨大缺口，迫使醫療機構轉向替代療法，並限制了生物皮膚庫服務的普及。因此，維持充足的同種異體移植皮膚庫存十分困難，這仍然是該領域進一步擴張和發展的主要障礙。

市場促進因素

燒燙傷和嚴重創傷發生率的不斷上升是全球皮膚庫市場的主要驅動力，迫切需要穩定的同種異體移植材料供應，用於急性傷口管理。嚴重燒燙傷通常會損傷大面積皮膚，因此必須即時使用生物敷料來預防感染、減少體液流失，並在永久性自體移植前促進傷口癒合。近期的損傷統計數據也印證了這種持續的需求。例如，在2025年10月，作為2025年全國燒燙傷意識日的一部分，兒童燒傷信託基金會宣布，根據國際燒燙傷損傷資料庫的數據，2022年至2024年間，因嚴重熱飲燒燙傷而入院接受專業燒燙傷護理的兒童患者人數增加了16.4%。創傷病例的增加直接給皮膚庫維持充足組織庫存的能力帶來了壓力。

同時，皮膚癌和黑色素瘤的發病率上升也顯著推動了市場成長。外科治療通常需要大範圍切除組織，因此需要進行植皮重組。惡性腫瘤發生率的上升推動了切除後重組治療方法的需求，並促進了自體皮膚和先進組織替代技術的應用。根據美國癌症協會於2025年1月發布的《2025年癌症事實與數據》報告，預計2025年美國將新增約104,960例黑色素瘤病例，凸顯了需要進行皮膚手術的患者群體不斷擴大。臨床需求的快速成長也反映在主要產業參與者的財務表現。 2025年2月，Vericel公司報告稱，其2024年全年與燒燙傷治療相關的收入淨額成長了22%，達到3990萬美元，表明皮膚修復行業擁有強勁的商業性發展勢頭。

市場挑戰

全球皮膚庫市場成長面臨的一大瓶頸是皮膚捐贈的持續短缺。這種短缺造成了供需之間的持續缺口，皮膚庫往往難以維持足夠的同種異體移植片庫存，以滿足大規模創傷治療的需求。當生物皮膚供應無法滿足燒燙傷科室的即時臨床需求時，醫療機構被迫轉向合成替代物和異質骨移植。這種對替代療法的依賴限制了人類皮膚庫服務的廣泛應用，並對從事同種異體移植片處理和儲存的機構的盈利能力產生了負面影響。

創傷性損傷的高發生率進一步加劇了組織短缺的影響。例如，兒童燒傷信託基金會報告稱，2024年有9,244名兒童遭受燒燙傷或燙傷。如此龐大的數字，僅僅代表一個人口群體，凸顯了組織供應的巨大壓力。由於捐獻率無法跟上此類損傷的高發生率，市場難以有效擴大規模。缺乏可靠的可用組織供應削弱了人們對生物銀行系統的信心，並阻礙了整個領域的發展。

市場趨勢

為了克服供應不穩定的問題，尋求傳統屍體異體移植替代方案的捐贈者正轉向混合型和生物工程皮膚產品，這從根本上重塑了市場格局。這項轉變的驅動力在於先進的細胞技術和合成基質，它們能夠提高傷口縫合率並降低排斥風險，從而有效克服捐贈者供應的限制。這些生物工程解決方案因其在慢性傷口和燒燙傷治療中提供的即用型便利性而獲得商業性認可，減少了對不可預測的生物庫存的依賴。這項商業性進展在主要企業的業績中得到了體現。 Integra Lifesciences公司在2025年2月發布的「2024會計年度第四季及全年業績」中報告稱，總收入達16.1億美元，凸顯了儘管面臨營運挑戰，但其再生組織產品組合的需求依然強勁。

同時，微創微移植技術的廣泛應用正在革新燒燙傷治療，顯著減少了治療大面積燒傷所需的供皮量。這些系統利用自體細胞採集技術生產移植片，其覆蓋的創面面積遠大於供皮區，從而減輕患者的身體負擔並促進上皮化。這項技術直接解決了供皮供不應求這一嚴峻挑戰，並正迅速成為燒傷治療的標準療法。為了佐證這一趨勢，Avita Medical在2025年2月發布的2024會計年度第四季及全年財務報告中宣布，由於其RECELL系統在創傷中心的廣泛應用，公司實現了6400萬美元的商業收入（同比成長29%）。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球皮膚庫市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依皮膚移植類型（自體移植與異體移植）
    • 依應用領域（燒燙傷患者、整形外科創傷患者、難癒合潰瘍、壓瘡等）
    • 依所有權類型（公有、私有、其他）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美皮膚庫市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章 歐洲皮膚庫市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區皮膚庫市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲皮膚庫市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲皮膚庫市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球皮膚庫市場：SWOT分析

第14章 波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • National Burns Centre
  • Yorkshire Regional Tissue Bank
  • Dutch National Skin Bank
  • Euro Skin Bank
  • Evangelical University Hospital of Curitiba（HUEC）Skin Bank
  • Ganga Hospital Skin Bank
  • Singapore General Hospital（SGH）Skin Bank
  • New York Firefighters Skin Bank
  • Helsinki Skin Bank
  • OGH Skin Bank

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 10693

The Global Skin Bank Market is projected to expand from USD 2.43 Billion in 2025 to USD 3.69 Billion by 2031, registering a CAGR of 7.21%. Skin banks function as specialized medical facilities focused on the harvesting, processing, preservation, and distribution of human skin allografts, which are crucial biological dressings for managing severe burns and significant tissue loss. This growth is primarily driven by the increasing frequency of burn injuries alongside advancements in graft preservation technologies that prolong tissue viability. Data from the American Burn Association highlights this urgent need, reporting 32,993 acute burn admissions across 114 centers in 2024, emphasizing the continuous demand for viable donor tissue to treat complex trauma cases.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 2.43 Billion
Market Size 2031USD 3.69 Billion
CAGR 2026-20317.21%
Fastest Growing SegmentNon-Healing Ulcer
Largest MarketNorth America

Despite these drivers, the market faces significant hurdles due to a chronic shortage of skin donations, a problem largely attributed to limited public awareness and cultural or religious reservations concerning post-mortem donation. This scarcity results in a considerable gap between supply and demand, compelling healthcare providers to depend on alternative treatments and restricting the broad availability of biological skin banking services. Consequently, the difficulty in maintaining sufficient allograft inventories persists as a major barrier to the further expansion and development of this sector.

Market Driver

The growing incidence of burn injuries and severe trauma serves as a major driver for the global skin bank market, creating an urgent need for a steady supply of allografts for acute wound management. Because severe burns frequently damage extensive skin surface areas, immediate biological dressings are essential to halt infection, minimize fluid loss, and expedite healing prior to permanent autografting. This sustained demand is underscored by recent injury statistics; for example, the Children's Burns Trust announced in October 2025, as part of 'National Burn Awareness Day 2025', that data from the International Burn Injury Database indicated a 16.4% increase in children admitted to specialist burns services for severe hot drink burns between 2022 and 2024. Such increases in trauma cases directly heighten the pressure on skin banks to secure sufficient tissue stocks.

In parallel, the rising prevalence of skin cancer and melanoma is substantially fueling market growth, as surgical treatments often require extensive tissue removal necessitating grafts for reconstruction. As malignancy rates increase, the demand for post-excision reconstructive options drives the use of banked skin and advanced substitutes. According to the 'Cancer Facts & Figures 2025' report released by the American Cancer Society in January 2025, approximately 104,960 new melanoma cases were projected in the United States for the year, highlighting the expanding patient population requiring dermatological surgery. This surge in clinical need is mirrored in the financial results of major sector participants; Vericel Corporation reported in February 2025 that its burn care net revenue grew by 22% to $39.9 million for the full year 2024, indicating strong commercial momentum within the skin repair industry.

Market Challenge

A critical bottleneck restricting the growth of the Global Skin Bank Market is the persistent shortage of skin donations. This scarcity generates a continuous gap between supply and demand, as skin banks often struggle to keep adequate inventories of the allografts needed for treating widespread trauma. When the supply of biological skin falls short of the immediate clinical requirements of burn units, medical providers are forced to rely on synthetic substitutes or xenografts. Such dependence on alternative therapies constrains the broader adoption of human skin banking services and negatively impacts the revenue potential for facilities engaged in allograft processing and storage.

The consequences of this shortage are further amplified by the high volume of trauma cases necessitating intervention. For instance, the Children's Burns Trust reported that 9,244 children suffered burns or scalds in 2024. This significant number, representing just one demographic segment, underscores the immense strain placed on available tissue supplies. Since the rate of donation fails to align with the high frequency of these injuries, the market faces difficulties in scaling operations efficiently. The inability to ensure a reliable supply of viable tissue ultimately weakens confidence in bio-banking systems and impedes the overall advancement of the sector.

Market Trends

The market is being fundamentally reshaped by a transition toward hybrid and bio-engineered skin products as providers look for alternatives to traditional cadaveric allografts to overcome supply inconsistencies. This shift is powered by advanced cellular and synthetic matrices that deliver improved wound closure rates and lower rejection risks, effectively countering the limitations of donor availability. These bio-engineered solutions are securing commercial traction by offering off-the-shelf convenience for the treatment of chronic wounds and burns, which reduces dependence on unpredictable biological inventories. This commercial progress is evident in the performance of major industry players; Integra LifeSciences reported total revenues of $1.61 billion in its 'Fourth Quarter and Full-Year 2024 Financial Results' in February 2025, highlighting the strong demand for its regenerative tissue portfolio despite operational hurdles.

Concurrently, the uptake of minimally invasive micro-grafting technologies is revolutionizing burn care by significantly decreasing the amount of donor skin needed to treat extensive injuries. These systems employ autologous cell harvesting to generate grafts that cover wound areas much larger than the donor site, thereby reducing patient trauma and hastening epithelialization. This technology directly tackles the critical challenge of limited donor skin availability and is quickly emerging as a standard of care for thermal burn management. Underscoring this trend, Avita Medical announced in February 2025, within its 'Fourth Quarter and Full Year 2024 Financial Results', that it achieved commercial revenue of $64.0 million, a 29% increase attributed to the growing use of its RECELL system in trauma centers.

Key Market Players

  • National Burns Centre
  • Yorkshire Regional Tissue Bank
  • Dutch National Skin Bank
  • Euro Skin Bank
  • Evangelical University Hospital of Curitiba (HUEC) Skin Bank
  • Ganga Hospital Skin Bank
  • Singapore General Hospital (SGH) Skin Bank
  • New York Firefighters Skin Bank
  • Helsinki Skin Bank
  • OGH Skin Bank

Report Scope

In this report, the Global Skin Bank Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Skin Bank Market, By Skin Graft

  • Autograft v/s Allograft

Skin Bank Market, By Application

  • Burns patient
  • Orthopedic Trauma patients
  • Non-Healing Ulcers
  • Pressure-Source
  • Others

Skin Bank Market, By Ownership

  • Public
  • Private
  • Others

Skin Bank Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Skin Bank Market.

Available Customizations:

Global Skin Bank Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Skin Bank Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Skin Graft (Autograft v/s Allograft)
    • 5.2.2. By Application (Burns patient, Orthopedic Trauma patients, Non-Healing Ulcers, Pressure-Source, Others)
    • 5.2.3. By Ownership (Public, Private, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Skin Bank Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Skin Graft
    • 6.2.2. By Application
    • 6.2.3. By Ownership
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Skin Bank Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Skin Graft
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By Ownership
    • 6.3.2. Canada Skin Bank Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Skin Graft
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By Ownership
    • 6.3.3. Mexico Skin Bank Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Skin Graft
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By Ownership

7. Europe Skin Bank Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Skin Graft
    • 7.2.2. By Application
    • 7.2.3. By Ownership
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Skin Bank Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Skin Graft
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By Ownership
    • 7.3.2. France Skin Bank Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Skin Graft
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By Ownership
    • 7.3.3. United Kingdom Skin Bank Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Skin Graft
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By Ownership
    • 7.3.4. Italy Skin Bank Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Skin Graft
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By Ownership
    • 7.3.5. Spain Skin Bank Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Skin Graft
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By Ownership

8. Asia Pacific Skin Bank Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Skin Graft
    • 8.2.2. By Application
    • 8.2.3. By Ownership
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Skin Bank Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Skin Graft
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By Ownership
    • 8.3.2. India Skin Bank Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Skin Graft
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By Ownership
    • 8.3.3. Japan Skin Bank Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Skin Graft
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By Ownership
    • 8.3.4. South Korea Skin Bank Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Skin Graft
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By Ownership
    • 8.3.5. Australia Skin Bank Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Skin Graft
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By Ownership

9. Middle East & Africa Skin Bank Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Skin Graft
    • 9.2.2. By Application
    • 9.2.3. By Ownership
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Skin Bank Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Skin Graft
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By Ownership
    • 9.3.2. UAE Skin Bank Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Skin Graft
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By Ownership
    • 9.3.3. South Africa Skin Bank Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Skin Graft
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By Ownership

10. South America Skin Bank Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Skin Graft
    • 10.2.2. By Application
    • 10.2.3. By Ownership
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Skin Bank Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Skin Graft
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By Ownership
    • 10.3.2. Colombia Skin Bank Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Skin Graft
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By Ownership
    • 10.3.3. Argentina Skin Bank Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Skin Graft
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By Ownership

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Skin Bank Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. National Burns Centre
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Yorkshire Regional Tissue Bank
  • 15.3. Dutch National Skin Bank
  • 15.4. Euro Skin Bank
  • 15.5. Evangelical University Hospital of Curitiba (HUEC) Skin Bank
  • 15.6. Ganga Hospital Skin Bank
  • 15.7. Singapore General Hospital (SGH) Skin Bank
  • 15.8. New York Firefighters Skin Bank
  • 15.9. Helsinki Skin Bank
  • 15.10. OGH Skin Bank

16. Strategic Recommendations

17. About Us & Disclaimer